- Home
- XAIR vs DSS Comparison
XAIR vs DSS Comparison
Compare XAIR & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XAIR | DSS |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 5.3M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XAIR | DSS |
|---|---|---|
| Price | $0.37 | $0.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 204.8K | ★ 2.8M |
| Earning Date | 06-16-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.09 | 42.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,705,000.00 | $2,085,000.00 |
| Revenue This Year | $122.00 | $1.21 |
| Revenue Next Year | $58.15 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 219.67 | N/A |
| 52 Week Low | $0.15 | $0.36 |
| 52 Week High | $3.78 | $1.90 |
Technical Indicators
Market Signals| Indicator | XAIR | DSS |
|---|---|---|
| Relative Strength Index (RSI) | 35.55 | 51.89 |
| Support Level | N/A | $0.36 |
| Resistance Level | $0.59 | $1.05 |
| Average True Range (ATR) | 0.04 | 0.13 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 17.09 | 30.23 |
Price Performance
Historical ComparisonAbout XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About DSS DSS Inc.
DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.